Juniper Investment Company’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.6M Buy
4,442,543
+465,584
+12% +$5.13M 10.75% 5
2026
Q1
$45.6M Buy
3,976,959
+466,626
+13% +$6.16M 14.56% 4
2025
Q4
$53.2M Buy
3,510,333
+663,278
+23% +$10.1M 18.3% 3
2025
Q3
$41.7M Buy
2,847,055
+377,729
+15% +$4.96M 15.94% 4
2025
Q2
$27.5M Buy
2,469,326
+331,952
+16% +$4.11M 11.32% 5
2025
Q1
$34.9M Buy
2,137,374
+200,125
+10% +$3.51M 15.68% 4
2024
Q4
$33.8M Buy
1,937,249
+1,070,656
+124% +$18.6M 13.33% 4
2024
Q3
$13.5M Buy
866,593
+557,308
+180% +$8.93M 5.65% 5
2024
Q2
$4.1M Buy
+309,285
New +$4.24M 1.97% 8

Other funds holding OFIX

Juniper Investment Company's OFIX Position: Q2 2026 in Review

Juniper Investment Company increased its Orthofix Medical (OFIX) stake by 12% in Q2 2026, buying an estimated $5.13M and bringing the position to 4,442,543 shares worth $40.6M. The position accounts for 10.75% of the portfolio, ranked #5.

Juniper Investment Company first reported a position in OFIX in Q2 2024 and has held it in 9 quarters since. The position peaked at $53.2M in Q4 2025. 144 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Juniper Investment Company held 4,442,543 shares of Orthofix Medical worth $40.6M as of Q2 2026.
  • Juniper Investment Company bought 465,584 Orthofix Medical shares in Q2 2026, an estimated $5.13M.
  • Orthofix Medical made up 10.75% of Juniper Investment Company's portfolio in Q2 2026, its #5 holding.
  • Juniper Investment Company first reported a position in Orthofix Medical in Q2 2024 and has held it in 9 quarters since.
  • Juniper Investment Company's Orthofix Medical position peaked at $53.2M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Juniper Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.